Stryker Corporation $SYK Shares Acquired by USS Investment Management Ltd

USS Investment Management Ltd lifted its position in shares of Stryker Corporation (NYSE:SYK) by 5.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 60,357 shares of the medical technology company’s stock after purchasing an additional 3,183 shares during the quarter. USS Investment Management Ltd’s holdings in Stryker were worth $21,214,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Venture Visionary Partners LLC grew its stake in Stryker by 9.9% in the 4th quarter. Venture Visionary Partners LLC now owns 6,351 shares of the medical technology company’s stock valued at $2,340,000 after acquiring an additional 572 shares during the period. Perryman Financial Advisory Inc. AD acquired a new stake in Stryker in the 4th quarter valued at $453,000. Public Employees Retirement Association of Colorado grew its stake in Stryker by 401.2% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 218,695 shares of the medical technology company’s stock valued at $76,865,000 after acquiring an additional 175,060 shares during the period. Resources Management Corp CT ADV grew its stake in Stryker by 4,557.4% in the 4th quarter. Resources Management Corp CT ADV now owns 21,424 shares of the medical technology company’s stock valued at $7,530,000 after acquiring an additional 20,964 shares during the period. Finally, Sargent Investment Group LLC acquired a new stake in Stryker in the 4th quarter valued at $337,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Insider Transactions at Stryker

In other news, Director Ronda E. Stryker sold 310,000 shares of Stryker stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the transaction, the director owned 1,924,880 shares in the company, valued at $601,005,282.40. The trade was a 13.87% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP M Kathryn Fink sold 5,220 shares of Stryker stock in a transaction on Monday, May 11th. The stock was sold at an average price of $283.85, for a total value of $1,481,697.00. Following the transaction, the vice president owned 13,137 shares in the company, valued at approximately $3,728,937.45. This represents a 28.44% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 323,264 shares of company stock worth $100,659,489 in the last quarter. Company insiders own 4.60% of the company’s stock.

Stryker Trading Down 0.0%

Shares of SYK opened at $312.14 on Monday. Stryker Corporation has a 52-week low of $281.00 and a 52-week high of $404.87. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. The firm’s fifty day moving average is $316.40 and its two-hundred day moving average is $343.79. The stock has a market cap of $119.66 billion, a PE ratio of 36.13, a price-to-earnings-growth ratio of 1.97 and a beta of 0.78.

Stryker (NYSE:SYK) last announced its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The business had revenue of $6.02 billion for the quarter, compared to analyst estimates of $6.34 billion. During the same period last year, the firm earned $2.84 EPS. The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Research analysts forecast that Stryker Corporation will post 14.98 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Tuesday, June 30th. Stryker’s payout ratio is currently 40.74%.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on SYK shares. Robert W. Baird set a $385.00 price target on shares of Stryker in a research note on Friday, May 1st. JPMorgan Chase & Co. dropped their price target on shares of Stryker from $445.00 to $400.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Needham & Company LLC dropped their price target on shares of Stryker from $454.00 to $418.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Barclays dropped their price target on shares of Stryker from $469.00 to $394.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Finally, Truist Financial reissued a “hold” rating and issued a $330.00 price target (down from $380.00) on shares of Stryker in a research note on Monday, May 4th. Sixteen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $395.33.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.